358 related articles for article (PubMed ID: 26659912)
21. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
Hirano D; Okada Y; Nagane Y; Satoh K; Mochida J; Yamanaka Y; Hirakata H; Yamaguchi K; Kawata N; Takahashi S; Henmi A
Urol Int; 2012; 89(1):71-7. PubMed ID: 22677699
[TBL] [Abstract][Full Text] [Related]
22. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
23. Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.
Fujita K; Tanigawa G; Imamura R; Nakagawa M; Hayashi T; Kishimoto N; Hosomi M; Yamaguchi S
Int J Urol; 2013 Jun; 20(6):594-601. PubMed ID: 23131052
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
[TBL] [Abstract][Full Text] [Related]
25. Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.
Syed JS; Nguyen KA; Suarez-Sarmiento A; Johnson K; Leapman MS; Raman JD; Shuch B
BJU Int; 2018 Jan; 121(1):124-129. PubMed ID: 28972702
[TBL] [Abstract][Full Text] [Related]
26. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W;
Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
[TBL] [Abstract][Full Text] [Related]
27. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M
Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372
[TBL] [Abstract][Full Text] [Related]
28. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Dalpiaz O; Ehrlich GC; Mannweiler S; Hernández JM; Gerger A; Stojakovic T; Pummer K; Zigeuner R; Pichler M; Hutterer GC
BJU Int; 2014 Sep; 114(3):334-9. PubMed ID: 24053693
[TBL] [Abstract][Full Text] [Related]
29. Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy.
Mouracade P; Velten M; Gigante M; Alenda O; Ploussard G; Obadia F; Timsit MO; Mejean A
Can J Urol; 2012 Feb; 19(1):6105-10. PubMed ID: 22316512
[TBL] [Abstract][Full Text] [Related]
30. Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery.
Almassi N; Gao T; Lee B; Stein RJ; Haber GP; Ornstein MC; Rini BI; Gilligan TD; Garcia JA; Stephenson AJ; Grivas P
Clin Genitourin Cancer; 2018 Dec; 16(6):e1237-e1242. PubMed ID: 30217764
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
Favaretto RL; Bahadori A; Mathieu R; Haitel A; Grubmüller B; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Cunha IW; Zequi SC; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Jacquet-Kammerer S; Bensalah K; Lotan Y; Bachmann A; Rink M; Briganti A; Shariat SF
World J Urol; 2017 Jan; 35(1):113-120. PubMed ID: 27129576
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy.
Moriarty MA; Uhlman MA; Bing MT; O'Donnell MA; Brown JA; Tracy CR; Deorah S; Nepple KG; Gupta A
BMC Urol; 2015 May; 15():45. PubMed ID: 26018765
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract.
Lee SH; Lin JS; Tzai TS; Chow NH; Tong YC; Yang WH; Chang CC; Cheng HL
Eur Urol; 1996; 29(3):266-70; discussion 271. PubMed ID: 8740029
[TBL] [Abstract][Full Text] [Related]
34. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
[TBL] [Abstract][Full Text] [Related]
35. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
[TBL] [Abstract][Full Text] [Related]
36. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
[TBL] [Abstract][Full Text] [Related]
37. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.
Holmäng S; Lele SM; Johansson SL
J Urol; 2007 Jul; 178(1):51-6. PubMed ID: 17574059
[TBL] [Abstract][Full Text] [Related]
38. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
40. [Large series of 114 cases with long-term follow-up of upper urinary tract urothelial tumors].
Izquierdo L; Truán D; Alvarez-Vijande R; Alcaraz A
Actas Urol Esp; 2010 Mar; 34(3):232-7. PubMed ID: 20416239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
